| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 07/13/2005 | EP1551430A2 Botulinum toxin dental therapies and procedures |
| 07/13/2005 | EP1551419A2 Relief of aids symptoms |
| 07/13/2005 | EP1551225A2 Cryopreservation of haptenized tumor cells |
| 07/13/2005 | EP1019188B1 Chemically-modified porous materials with an electroneutral hydrophilic outer surface |
| 07/13/2005 | CN1639569A Methods and compositions for inducing an immune response |
| 07/13/2005 | CN1639566A Therapeutic properties of oils |
| 07/13/2005 | CN1639325A A method for producing recombinant viruses using site-specific recombination |
| 07/13/2005 | CN1639323A Vesicles derived from T cells, production and uses |
| 07/13/2005 | CN1639322A Recombinant spores |
| 07/13/2005 | CN1639321A Bacterial spores |
| 07/13/2005 | CN1639318A Antimicrobial composition |
| 07/13/2005 | CN1639317A Probiotic lactobacillus salivarius strains |
| 07/13/2005 | CN1638822A Compositions comprising undifferentiated fetal cells for the treatment of skin disorders |
| 07/13/2005 | CN1638808A Coupling proteins to a modified polysaccharide |
| 07/13/2005 | CN1638795A MVA expressing modified HIV envelope, GAG, and pol genes |
| 07/13/2005 | CN1638787A Helicobacter pylori adhesion inhibitor |
| 07/13/2005 | CN1638784A External compositions for the skin |
| 07/13/2005 | CN1638783A Treatment of muscular distrophy with cord blood cells |
| 07/13/2005 | CN1638782A Anti-white spot syndrome virus IGY |
| 07/13/2005 | CN1638780A Methods for particle-assisted polynucleotide immunization using a pulsed electric field |
| 07/13/2005 | CN1636594A Angiostatin and use of the same for inhibition of angiogenesis |
| 07/13/2005 | CN1636577A Vaginal care composition |
| 07/13/2005 | CN1210066C Cloning pigs using donor nuclei from differentiated cells |
| 07/13/2005 | CN1210055C Moschus safflower capsules for treating femoral necrosis, myelitis and fracture |
| 07/13/2005 | CN1210046C Medicine for treating muscle atrophy |
| 07/13/2005 | CN1210044C Chinese medicine for gastrointestinal cances and its preparation |
| 07/13/2005 | CN1210043C Chinese herbal medicine for treating pains of neck shoulder, waist and legs |
| 07/13/2005 | CN1210037C Glucosamine and egg for reducing inflammation |
| 07/13/2005 | CN1209978C Nutritive health-care food for supplementing nucleic acid and its preparing process |
| 07/12/2005 | US6916834 Preparations and use of an Ah receptor ligand, 2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 07/12/2005 | US6916789 Synthetic polypeptide ligand for use in the treatment of cardiovascular, tumor, viral and hypertensive disorders |
| 07/12/2005 | US6916783 Proliferation of chondrocytes to increase the biosynthesis of collagen administering angiotensinogen, angiotensin I and II including analogues, fragments and analogues and type 2 receptor agonists; amino acid sequences; kits |
| 07/12/2005 | US6916654 Universal donor cells |
| 07/12/2005 | US6916640 Multi-layer cell encapsulation for tissue engineering |
| 07/12/2005 | US6916625 Artery- and vein-specific proteins and uses therefor |
| 07/12/2005 | US6916615 Collection of prokaryotic DNA for two hybrid systems Helicobacter pylori protein-protein interactions and application thereof |
| 07/12/2005 | US6916492 Natural nontoxic multicolor fluorescent protein dye from a marine invertebrate, compositions containing the said dye and its uses |
| 07/12/2005 | US6916491 Fungus inhibiting biological compound |
| 07/12/2005 | US6916471 Amplification of nitroso compouds in erythrocytes; obtain mammal, inject with therapeutic agent, monitor concentration levels of preferential nitroso compounds |
| 07/12/2005 | US6916470 Methods for use of mpl ligands with primitive human stem cells |
| 07/12/2005 | US6916419 Contacting a sample in a flowable liquid state with a solid substrate comprised of a prion complexing agent; allowing the sample to remain in contact with the substrate for time such that prion in the sample bind to the substrate |
| 07/12/2005 | CA2452172A1 Methods and compositions for modulating cell activation and uses thereof |
| 07/07/2005 | WO2005061698A1 A respiratory syncytial virus with a genomic deficiency complemented in trans |
| 07/07/2005 | WO2005061697A1 Process for producing engineered targeted t cell and medicine |
| 07/07/2005 | WO2005061696A1 Method for isolating cells from mammary secretion |
| 07/07/2005 | WO2005061695A1 Method for isolating cells from mammary secretion |
| 07/07/2005 | WO2005060987A1 A composition for cartilage therapeutics and using method thereof |
| 07/07/2005 | WO2005060937A1 Compressed tablets comprising viable probiotic microorganisms |
| 07/07/2005 | WO2005060709A2 Methods of use of probiotic bifidobacteria for companion animals |
| 07/07/2005 | WO2005060707A2 Methods of use of probiotic lactobacilli for companion animals |
| 07/07/2005 | WO2005060592A2 Process for producing t lymphocytes |
| 07/07/2005 | WO2005060515A2 An oncolytic adenovirus |
| 07/07/2005 | WO2005060498A2 Composition and method for inhibiting salmonella and campylobacter colonization in poultry |
| 07/07/2005 | WO2005044844A3 Protozoan strains of reduced virulence and use thereof |
| 07/07/2005 | WO2005028640A8 Method for isolating hepatocytes |
| 07/07/2005 | WO2005017095A3 A stable liquid probiotic composition, preparation and applications thereof |
| 07/07/2005 | WO2005016288A3 Methods and compositions for treatment of viral diseases |
| 07/07/2005 | WO2004099364A3 Multicellular compositions of pluripotent human embryonic stem cells and cancer cells |
| 07/07/2005 | WO2004022579A3 Cellular delivery of natriuretic peptides |
| 07/07/2005 | WO2003083069A8 Activation of tumor-reactive lymphocytes via antibodies or genes recognizing cd3 or 4-1bb |
| 07/07/2005 | US20050148748 Copolymers and blood filter using the same |
| 07/07/2005 | US20050148629 Hydroxyamidealkylsulfonamide compounds for anthrax treatment |
| 07/07/2005 | US20050148541 Treatment and prevention of HIV and other viral infections |
| 07/07/2005 | US20050148526 Methods of obtaining isoform specific expression in mammalian cells |
| 07/07/2005 | US20050148073 Induction of hepatocyte proliferation in vitro by inhibition of cell cycle inhibitors |
| 07/07/2005 | US20050148072 Human liver progenitors |
| 07/07/2005 | US20050148062 Transgenic microorganisms comprising apoptosis associated genes for use as tools in identifying modulators for prevention and treatment of cell proliferative disorders |
| 07/07/2005 | US20050148014 Regulation of human P2Y1-like G protein-coupled receptor |
| 07/07/2005 | US20050147700 Preventative and treatment effects of Morinda citrifolia on diabetes and its related conditions |
| 07/07/2005 | US20050147695 Method of preventing parturient hypocalcemia in animals and compositions used therein |
| 07/07/2005 | US20050147652 Cell delivery system |
| 07/07/2005 | US20050147649 Method and dietary composition for improving fat digestibility |
| 07/07/2005 | US20050147597 Isolating autologous mononuclear cells and transplanting locally into injured tissue |
| 07/07/2005 | US20050147596 Preferably, the fibroblasts are obtained from a tissue which is the same type of tissue as that of which the wound is comprised or a tissue in which the fistula exists; also preferably, the fibroblasts are cultured in the animal's own serum. |
| 07/07/2005 | US20050147594 Providing living cells enclosed within a bead, covering beaded cells with a semi-permeable layer made of a N-5-azido-2-nitrobenzoyloxysuccinimide crosslinked polylysine to obtain a product, photoactivating crosslinking agent to covalently link semipermeable layer to bead and biocompatible layer |
| 07/07/2005 | US20050147592 Correcting underlying genetic defect; delivering heterologous gene encoding metabolic protein causing transduction of cells resulting in expression from transformed cell genetics |
| 07/07/2005 | US20050147591 Methods and compositions for viral enhancement of cell killing |
| 07/07/2005 | US20050147586 Novel therapeutic processes and useful compositions therefor |
| 07/07/2005 | DE10357970A1 Lösungsmittel für biogene pharmazeutische Wirkstoffe Solvent for biogenic active pharmaceutical ingredients |
| 07/07/2005 | CA2782052A1 Methods of use of probiotic lactobacilli for companion animals |
| 07/07/2005 | CA2551009A1 A respiratory syncytial virus with a genomic deficiency complemented in trans |
| 07/07/2005 | CA2549937A1 Human anti-idiotypic antibody fragments that mimic her-2/neu |
| 07/07/2005 | CA2545696A1 An oncolytic adenovirus |
| 07/07/2005 | CA2453198A1 Quantification and generation of immune suppressive exosomes |
| 07/06/2005 | EP1550722A1 Serotype of adenovirus and uses thereof |
| 07/06/2005 | EP1550719A1 Methods and medicament for inhibition the expression of a defined gene |
| 07/06/2005 | EP1550715A1 Method for the regeneration of tissue |
| 07/06/2005 | EP1550454A1 Extracorporeal photopheresis in combination with anti-TNF treatment |
| 07/06/2005 | EP1550449A1 Antitumor agents with the use of hsv |
| 07/06/2005 | EP1549761A1 Methods and compositions for the modification of nucleic acids |
| 07/06/2005 | EP1549756A2 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 07/06/2005 | EP1549740A2 Oligodendrocyte production from multipotent neural stem cells |
| 07/06/2005 | EP1549738A2 Keratinocytes expressing exogenous angiogenic growth factors |
| 07/06/2005 | EP1549737A1 Isolation of target cells, capillaries and microorgans |
| 07/06/2005 | EP1549672A2 Ablated slam-dependent entry |
| 07/06/2005 | EP1549358A1 Composition for filling bone defects |
| 07/06/2005 | EP1549336A2 Prevention and/or treatment of inflammatory bowel disease using pyy or agonists thereof |
| 07/06/2005 | EP1549328A2 Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin |
| 07/06/2005 | EP1549277A1 Induction and maintenance of tolerance to composite tissue allografts |
| 07/06/2005 | EP1549155A1 Food additive and/or drinking water additive for domestic animals |